WHO recommends that persons who have survived/recovered from filovirus disease be offered structured follow-up after discharge.
- Année
- 2026
- Institution
- Non disponible
Recommandé en faveur
Forte
Certitude des données probantes
Modérée
Résultats : 1 - 10 sur 2,445
Résultats : 1 - 10 sur 2,445
WHO recommends that Ervebo® should not be used outside of controlled research settings in response to the current Bundibugyo virus ( BDBV ) outbreak.
- Année
- 2026
- Institution
- Non disponible
Recommandation en contexte de recherche
Uniquement dans des contextes de recherche
Certitude des données probantes
Très faible
WHO suggests for the use of tranexamic acid in patients with confirmed filovirus disease and postpartum haemorrhage.
- Année
- 2026
- Institution
- Non disponible
Recommandé en faveur
Conditionnelle
Certitude des données probantes
Faible
Intravenous (IV) aminophylline should not be used as second-line therapy for severe paediatric asthma exacerbations in health care facilities if alternative second-line options are available.
- Année
- 2026
- Institution
- World Health Organization
Recommandé contre
Conditionnelle
Certitude des données probantes
Faible
In children and adolescents (aged 0–19 years) with sickle-cell disease (SCD) at risk of recurrent stroke (e.g. history of stroke, haemoglobin S >30% and haemoglobin <9 g/dL), regular blood transfusion with iron chelation therapy is suggested rather than hydroxyurea therapy alone for secondary stroke prevention.
- Année
- 2026
- Institution
- World Health Organization
Recommandé en faveur
Conditionnelle
Certitude des données probantes
Très faible
WHO suggests against mass testing in community settings to reduce the transmission of influenza viruses during influenza epidemics and pandemics.
- Année
- 2026
- Institution
- World Health Organization
Recommandé contre
Conditionnelle
Certitude des données probantes
Très faible
WHO suggests against travel restrictions (including border closures) to reduce the transmission of influenza viruses in the community during influenza epidemics and pandemics.
- Année
- 2026
- Institution
- World Health Organization
Recommandé contre
Conditionnelle
Certitude des données probantes
Très faible
WHO suggests against stay-at-home provisions (including recommendations or orders) to reduce the transmission of influenza viruses in the community during influenza epidemics and pandemics.
- Année
- 2026
- Institution
- World Health Organization
Recommandé contre
Conditionnelle
Certitude des données probantes
Faible
Combination inhaler (steroid plus fast-onset long-acting beta2 agonist) maintenance and reliever therapy (MART) should be considered for children with persistent asthma symptoms requiring regular inhaled corticosteroids (ICS) treatment.
- Année
- 2026
- Institution
- World Health Organization
Recommandé en faveur
Conditionnelle
Certitude des données probantes
Modérée
In children and adolescents (aged 0–19 years) with suspected sickle-cell disease (SCD), the use of lateral flow immunoassay and micro-engineered haemoglobin electrophoresis point-ofcare tests (POCTs) is suggested for diagnosis in settings where standard laboratory-based haemoglobin fractionation or DNA-based tests are not available.
- Année
- 2026
- Institution
- World Health Organization
Recommandé en faveur
Conditionnelle
Certitude des données probantes
Faible